Susquehanna International Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $513K | Sell |
32,073
-16,511
| -34% | -$264K | ﹤0.01% | 4289 |
|
2025
Q1 | $739K | Buy |
48,584
+35,077
| +260% | +$534K | ﹤0.01% | 3795 |
|
2024
Q4 | $274K | Buy |
13,507
+2,546
| +23% | +$51.6K | ﹤0.01% | 4871 |
|
2024
Q3 | $282K | Sell |
10,961
-30,243
| -73% | -$778K | ﹤0.01% | 4380 |
|
2024
Q2 | $530K | Sell |
41,204
-48,681
| -54% | -$626K | ﹤0.01% | 3445 |
|
2024
Q1 | $2.06M | Buy |
89,885
+73,013
| +433% | +$1.67M | ﹤0.01% | 1790 |
|
2023
Q4 | $442K | Buy |
16,872
+15,030
| +816% | +$393K | ﹤0.01% | 4033 |
|
2023
Q3 | $51.8K | Sell |
1,842
-1,363
| -43% | -$38.3K | ﹤0.01% | 5109 |
|
2023
Q2 | $97.4K | Buy |
3,205
+1,765
| +123% | +$53.7K | ﹤0.01% | 5010 |
|
2023
Q1 | $27.1K | Buy |
+1,440
| New | +$27.1K | ﹤0.01% | 5566 |
|
2022
Q2 | – | Sell |
-1,721
| Closed | -$169K | – | 6679 |
|
2022
Q1 | $169K | Buy |
+1,721
| New | +$169K | ﹤0.01% | 4925 |
|